Form 424B5 ARTELO BIOSCIENCES, INC.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Artelo Biosciences files $6.5M at-the-market offering prospectus
May 26, 2026 4:50 PM EDTArtelo Biosciences (NASDAQ: ARTL) filed a prospectus supplement for an at-the-market offering program to sell up to $6.53 million of common stock through H.C. Wainwright & Co. as exclusive sales agent.
The biotechnology company entered into an At the Market Offering Agreement with H.C. Wainwright dated... More
